BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu Y, Ni J, Chen J, Ma G, Zhao M, Zhu S, Shi T, Zhu J, Huang Z, Zhang J, Chen J. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease. Mol Ther 2020;28:1214-28. [PMID: 32087149 DOI: 10.1016/j.ymthe.2020.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lopez-Santalla M, Garin MI. Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases. Biomedicines 2021;9:1507. [PMID: 34829736 DOI: 10.3390/biomedicines9111507] [Reference Citation Analysis]
2 Yao X, Ma Y, Zhou W, Liao Y, Jiang Z, Lin J, He Q, Wu H, Wei W, Wang X, Björklund M, Ouyang H. In-cytoplasm mitochondrial transplantation for mesenchymal stem cells engineering and tissue regeneration. Bioeng Transl Med 2022;7:e10250. [PMID: 35111950 DOI: 10.1002/btm2.10250] [Reference Citation Analysis]
3 Andrzejewska A, Dabrowska S, Lukomska B, Janowski M. Mesenchymal Stem Cells for Neurological Disorders. Adv Sci (Weinh) 2021;8:2002944. [PMID: 33854883 DOI: 10.1002/advs.202002944] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 36.0] [Reference Citation Analysis]
4 Li Q, Lian Y, Deng Y, Chen J, Wu T, Lai X, Zheng B, Qiu C, Peng Y, Li W, Xiang AP, Zhang X, Ren J. mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD. Mol Ther Nucleic Acids 2021;26:222-36. [PMID: 34513306 DOI: 10.1016/j.omtn.2021.07.009] [Reference Citation Analysis]
5 Wang X, He Z, Zhao X. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review). Exp Ther Med 2021;21:319. [PMID: 33732292 DOI: 10.3892/etm.2021.9750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]